54298-5 |
Hexanoylcarnitine (C6) |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Hexanoylcarnitine (C6) [Moles/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54298-5 |
|
|
|
|
Both |
|
|
|
0 |
Hexanoylcarn Ur-sCnc |
|
|
|
N |
|
C6; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
54299-3 |
Homocitrulline |
SCnc |
Amnio fld |
Pt |
Qn |
|
|
ACTIVE |
Homocitrulline [Moles/volume] in Amniotic fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54299-3 |
|
|
|
|
Both |
|
|
|
0 |
Homocitrulline Amn-sCnc |
|
|
|
N |
|
AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Chemistry; Hci; HOMCIT; Homocit; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
543-9 |
Mycobacterium sp |
Prid |
XXX |
Pt |
Nom |
Organism specific culture |
|
ACTIVE |
Mycobacterium sp identified in Specimen by Organism specific culture |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
543-9 |
|
Organism specific culture |
|
|
Both |
|
|
|
0 |
Mycobacterium Spec Cult |
|
|
|
|
|
Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Myco; Mycobact; Nominal; Other; Point in time; Random; Spec; species; spp; To be specified in another part of the message; Tuberculosis; UniversalLabOrders; Unspecified |
2.78 |
1 |
|
|
|
|
|
|
|
|
|
|
Release 2.78: COMPONENT: Removed "Identified" from the component because it is implied by the Property "Prid"; |
20 |
5430-4 |
CD120b |
ACnc |
WBC |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated CD120B cells/100 cells in Blood |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CELLMARK |
|
5430-4 |
|
|
|
|
|
|
|
|
0 |
Deprecated CD120b WBC-aCnc |
|
|
|
|
|
Arbitrary concentration; CELL MARKERS; Leukocytes; p75; Point in time; QNT; Quan; Quant; Quantitative; Random; TNFR p80; TNFRII; WBCs; White blood cells |
2.69 |
1 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
54300-9 |
Homocysteine |
SCnc |
Amnio fld |
Pt |
Qn |
|
|
ACTIVE |
Homocysteine [Moles/volume] in Amniotic fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54300-9 |
|
|
|
|
Both |
|
|
|
0 |
Hcys Amn-sCnc |
|
|
|
N |
|
AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Chemistry; Genetics; Gyn; Gynecology; HCY; Hcys; Hcyst; Heredity; Heritable; Homocyst(e)ine; Inherited; Level; Neuro; Neurology; OB; ObGyn; Obstetrics; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
54301-7 |
Homocysteine |
SCnc |
Bld.dot |
Pt |
Qn |
|
|
ACTIVE |
Homocysteine [Moles/volume] in DBS |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54301-7 |
|
|
|
|
Both |
|
|
|
0 |
Hcys DBS-sCnc |
|
|
|
N |
|
Blood; Cardio; Cardiology; Chemistry; DBS; Dried blood spot; Filter paper; FP; HCY; Hcys; Hcyst; Heart Disease; Homocyst(e)ine; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
54302-5 |
Homocystine |
SCnc |
Bld.dot |
Pt |
Qn |
|
|
ACTIVE |
Homocystine [Moles/volume] in DBS |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54302-5 |
|
|
|
|
Both |
|
|
|
0 |
(Hcys)2 DBS-sCnc |
|
|
|
N |
|
(Hcys)2; Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Homocyst(e)ine; Homocystin; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
54303-3 |
Hydroxylysine |
SCnc |
Bld.dot |
Pt |
Qn |
|
|
ACTIVE |
Hydroxylysine [Moles/volume] in DBS |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54303-3 |
|
|
|
|
Both |
|
|
|
0 |
OH-Lysine DBS-sCnc |
|
|
|
N |
|
Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Hydroxy lysine; Hydroxyl; Level; OH-Lysine; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
54304-1 |
Isobutyrylglycine |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Isobutyrylglycine [Moles/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54304-1 |
|
|
|
|
Both |
|
|
|
0 |
Isobutyrylgly Ur-sCnc |
|
|
|
N |
|
Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
54305-8 |
Isovalerylcarnitine+Methylbutyrylcarnitine (C5) |
SCnc |
CSF |
Pt |
Qn |
|
|
ACTIVE |
Isovalerylcarnitine+Methylbutyrylcarnitine (C5) [Moles/volume] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54305-8 |
|
|
|
|
Both |
|
|
|
0 |
Isovaleryl+MeButyrylcarn CSF-sCnc |
|
|
|
N |
|
C5; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Isovaleryl+MeButyrylcarn; Isovaleryl-2-Methylbutyrylcarnitine; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
54306-6 |
Isovalerylcarnitine+Methylbutyrylcarnitine (C5) |
SCnc |
Amnio fld |
Pt |
Qn |
|
|
ACTIVE |
Isovalerylcarnitine+Methylbutyrylcarnitine (C5) [Moles/volume] in Amniotic fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54306-6 |
|
|
|
|
Both |
|
|
|
0 |
Isovaleryl+MeButyrylcarn Amn-sCnc |
|
|
|
N |
|
AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; C5; Chemistry; Isovaleryl+MeButyrylcarn; Isovaleryl-2-Methylbutyrylcarnitine; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
54307-4 |
Isovalerylcarnitine+Methylbutyrylcarnitine (C5) |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Isovalerylcarnitine+Methylbutyrylcarnitine (C5) [Moles/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54307-4 |
|
|
|
|
Both |
|
|
|
0 |
Isovaleryl+MeButyrylcarn Ur-sCnc |
|
|
|
N |
|
C5; Chemistry; Isovaleryl+MeButyrylcarn; Isovaleryl-2-Methylbutyrylcarnitine; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
54308-2 |
Isovalerylglycine |
SCnc |
CSF |
Pt |
Qn |
|
|
ACTIVE |
Isovalerylglycine [Moles/volume] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54308-2 |
|
|
|
|
Both |
|
|
|
0 |
Isovalerylgly CSF-sCnc |
|
|
|
N |
|
Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
54309-0 |
Lactate/Pyruvate |
SRto |
CSF |
Pt |
Qn |
|
|
ACTIVE |
Lactate/Pyruvate [Molar ratio] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
54309-0 |
|
|
|
|
Observation |
|
|
|
0 |
Lactate/Pyruvate CSF-sRto |
|
|
|
N |
|
2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Lact; Lactic acid; L-lactate; Point in time; Pyruvic acid; QNT; Quan; Quant; Quantitative; Random; Scrto; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration ratio; Substance ratio |
2.42 |
2.27 |
|
|
|
|
|
|
|
|
|
|
|
0 |
5431-2 |
CD122 |
ACnc |
WBC |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated CD122 cells/100 cells in Blood |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CELLMARK |
|
5431-2 |
|
|
|
|
|
|
|
|
0 |
Deprecated CD122 WBC-aCnc |
|
|
|
|
|
Arbitrary concentration; CELL MARKERS; IL-2Rbeta; Interleukin 2 receptor beta chain; Leukocytes; Point in time; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells |
2.69 |
1 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
54310-8 |
Linoleoylcarnitine (C18:2)/Creatinine |
SRto |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Linoleoylcarnitine (C18:2)/Creatinine [Molar ratio] in Urine |
|
MIN |
DefinitionDescription |
|
|
umol/mmol creatinine |
|
|
|
|
|
|
CHEM |
|
54310-8 |
|
|
|
|
Both |
|
|
|
0 |
Linoleoylcarn/Creat Ur-sRto |
|
|
|
N |
|
C18:2; Chemistry; CR; Crea; Creat; II; Linoleylcarnitine; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/mmol{creat} |
|
|
|
0 |
54311-6 |
Linoleoylcarnitine (C18:2) |
SCnc |
CSF |
Pt |
Qn |
|
|
ACTIVE |
Linoleoylcarnitine (C18:2) [Moles/volume] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54311-6 |
|
|
|
|
Both |
|
|
|
0 |
Linoleoylcarn CSF-sCnc |
|
|
|
N |
|
C18:2; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; II; Level; Linoleylcarnitine; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
54312-4 |
Linoleoylcarnitine (C18:2) |
SCnc |
Amnio fld |
Pt |
Qn |
|
|
ACTIVE |
Linoleoylcarnitine (C18:2) [Moles/volume] in Amniotic fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54312-4 |
|
|
|
|
Both |
|
|
|
0 |
Linoleoylcarn Amn-sCnc |
|
|
|
N |
|
AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; C18:2; Chemistry; II; Level; Linoleylcarnitine; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
54313-2 |
Linoleoylcarnitine (C18:2) |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Linoleoylcarnitine (C18:2) [Moles/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54313-2 |
|
|
|
|
Both |
|
|
|
0 |
Linoleoylcarn Ur-sCnc |
|
|
|
N |
|
C18:2; Chemistry; II; Level; Linoleylcarnitine; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
54314-0 |
Malonylcarnitine (C3-DC)/Creatinine |
SRto |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Malonylcarnitine (C3-DC)/Creatinine [Molar ratio] in Urine |
|
MIN |
DefinitionDescription |
|
|
umol/mmol creatinine |
|
|
|
|
|
|
CHEM |
|
54314-0 |
|
|
|
|
Both |
|
|
|
0 |
Malonylcarn/Creat Ur-sRto |
|
|
|
N |
|
C3DC; C3-DC; Chemistry; CR; Crea; Creat; Dicarboxylic carnitine; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/mmol{creat} |
|
|
|
0 |
54315-7 |
Methylmalonate |
SCnc |
CSF |
Pt |
Qn |
|
|
ACTIVE |
Methylmalonate [Moles/volume] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54315-7 |
|
|
|
|
Both |
|
|
|
0 |
Methylmalonate CSF-sCnc |
|
|
|
N |
|
Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Methylmalonic acid; Methylmalonic Acidemia; MMA; Point in time; Propionic acidemia; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
54316-5 |
Methylmalonylcarnitine (C4-DC)/Creatinine |
SRto |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Methylmalonylcarnitine (C4-DC)/Creatinine [Molar ratio] in Urine |
|
MIN |
DefinitionDescription |
|
|
umol/mmol creatinine |
|
|
|
|
|
|
CHEM |
|
54316-5 |
|
|
|
|
Both |
|
|
|
0 |
Me-malonylcarn/Creat Ur-sRto |
|
|
|
N |
|
C4DC; C4-DC; C4-DCC; Chemistry; CR; Crea; Creat; Dicarboxylic carnitine; Me-malonylcarn; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/mmol{creat} |
|
|
|
0 |
54317-3 |
Methylmalonylcarnitine (C4-DC) |
SCnc |
CSF |
Pt |
Qn |
|
|
ACTIVE |
Methylmalonylcarnitine (C4-DC) [Moles/volume] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54317-3 |
|
|
|
|
Both |
|
|
|
0 |
Me-malonylcarn CSF-sCnc |
|
|
|
N |
|
C4DC; C4-DC; C4-DCC; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Dicarboxylic carnitine; Level; Me-malonylcarn; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
54318-1 |
Methylmalonylcarnitine (C4-DC) |
SCnc |
Amnio fld |
Pt |
Qn |
|
|
ACTIVE |
Methylmalonylcarnitine (C4-DC) [Moles/volume] in Amniotic fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54318-1 |
|
|
|
|
Both |
|
|
|
0 |
Me-malonylcarn Amn-sCnc |
|
|
|
N |
|
AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; C4DC; C4-DC; C4-DCC; Chemistry; Dicarboxylic carnitine; Level; Me-malonylcarn; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
54319-9 |
Methylmalonylcarnitine (C4-DC) |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Methylmalonylcarnitine (C4-DC) [Moles/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
54319-9 |
|
|
|
|
Both |
|
|
|
0 |
Me-malonylcarn Ur-sCnc |
|
|
|
N |
|
C4DC; C4-DC; C4-DCC; Chemistry; Dicarboxylic carnitine; Level; Me-malonylcarn; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn |
2.7 |
2.27 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |